Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

216.58

-4.17 (-1.89%)

At close: Sep 14, 2026, 4:00 PM EDT

217.00

+0.42 (0.19%)

After-hours: Sep 14, 2026, 7:51 PM EDT

Axsome Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	776.57	638.5	385.69	270.6	50.04	-
Revenue Growth	56.87%	65.55%	42.53%	440.80%	-	-
Cost of Revenue	52.53	47.48	33.3	26.07	4.1	-
Gross Profit	724.04	591.02	352.39	244.54	45.94	-
Selling, General & Admin	712.67	570.6	411.36	323.12	159.25	66.65
Research & Development	187.86	183.28	187.08	97.94	57.95	58.06
Amortization of Goodwill & Intangibles	6.38	6.38	6.39	6.38	4.14	-
Operating Expenses	906.9	760.25	604.83	427.44	221.34	124.71
Operating Income	-182.86	-169.24	-252.44	-182.91	-175.4	-124.71
Interest Expense	-12.88	-15.93	-21.58	-20.03	-9.66	-5.7
Interest & Investment Income	7.86	9.37	15.01	13.58	2.32	-
EBT Excluding Unusual Items	-187.88	-175.79	-259.01	-189.36	-182.74	-130.4
Merger & Restructuring Charges	-	-	-	-	-1.1	-
Other Unusual Items	-3.21	-7.91	-28.12	-48.92	-3.3	-
Pretax Income	-191.09	-183.7	-287.13	-238.28	-187.13	-130.4
Income Tax Expense	0.56	-0.53	0.09	0.96	-	-
Net Income	-191.64	-183.17	-287.22	-239.24	-187.13	-130.4
Net Income to Common	-191.64	-183.17	-287.22	-239.24	-187.13	-130.4
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	51	50	48	45	41	38
Shares Outstanding (Diluted)	51	50	48	45	41	38
Shares Change	4.44%	3.82%	5.48%	11.73%	8.07%	1.11%
EPS (Basic)	-3.76	-3.68	-5.99	-5.27	-4.60	-3.47
EPS (Diluted)	-3.76	-3.68	-5.99	-5.27	-4.60	-3.47
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-71.96	-93.89	-128.68	-145.66	-117.21	-108.53
Free Cash Flow Per Share	-1.41	-1.89	-2.69	-3.21	-2.88	-2.88
Gross Margin	93.24%	92.56%	91.36%	90.37%	91.81%	-
Operating Margin	-23.55%	-26.51%	-65.45%	-67.59%	-350.54%	-
Profit Margin	-24.68%	-28.69%	-74.47%	-88.41%	-373.99%	-
Free Cash Flow Margin	-9.27%	-14.70%	-33.36%	-53.83%	-234.25%	-
EBITDA	-172.92	-160.17	-244.48	-176.07	-171	-124.63
EBITDA Margin	-22.27%	-25.09%	-63.39%	-65.07%	-	-
D&A For EBITDA	9.94	9.06	7.96	6.83	4.4	0.08
EBIT	-182.86	-169.24	-252.44	-182.91	-175.4	-124.71
EBIT Margin	-23.55%	-26.51%	-65.45%	-67.59%	-	-
Revenue as Reported	776.57	638.5	385.69	270.6	50.04	-
Advertising Expenses	-	167.1	101.2	100.3	35.3	-

SEC Filings: 10-K · 10-Q